Sign in
4

Changes in Ownership

BridgeBio Pharma, Inc. Filed Acc 0000899243-20-032507

Chief Business Officer sold 10,000 shares at an average $51.52 ($515,204)

  • Chief Business Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HENDERSON MICHAEL THOMAS · Chief Business Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-01 Exercise or conversion : show line 1 in the form +10,000 $1.05 $10,500 284,211 D
2020-12-01 Sale : show line 2 in the form −3,028 $51.12 $154,796 281,183 D
2020-12-01 Sale : show line 3 in the form −6,972 $51.69 $360,408 274,211 D
Open-market sales · 10,000 sh · avg $51.52 · $515,204

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-01 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −10,000 8,282 D
Loading xslF345X03/doc4.xml…